Well said Warp. I am both a Todos and AMBS investor who certainly took one on the chin with AMBS but still believe AMBS can rise from the ashes with the help of the 78M shares it owns in Todos. Even a modest rise in Todos shares could give AMBS the seed money to resume clinical trials in their portfolio of products...ELTO, MANF...etc. It appears there are some activities going on behind the scenes at AMBS that would indicate they are preparing for the above...this is all speculation on my part.